(Q74333038)

English

Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety

scientific article published on 01 July 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

K Roger Aoki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

923-928

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The action of botulinum toxin on the neuro-muscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Response and immunoresistance to botulinum toxin injections

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Restriction of secretory granule motion near the plasma membrane of chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic botulinum type A toxin: factors affecting potency.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridium botulinum toxins: nature and preparation for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

SNAREs contribute to the specificity of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human response to botulinum toxin injection: type B compared with type A

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-0101%2802%2900086-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-0101(02)00086-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74333038&oldid=1789227280"